Siemens to distribute Calypso in EU

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Calypso Medical Technologies, a developer of real-time localization technology used for the tracking of tumor targets, has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso System in Europe.

Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years, according to the Seattle-based Calypso.

Last year, Calypso entered into a master development agreement with Siemens to jointly develop products integrating the Calypso System with the Siemens Artiste linear accelerator and other Siemens radiotherapy technologies.

 

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.